Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer

Biomedicine and Pharmacotherapy

Volumn 68, Issue 6, 2014, Pages 729-736

  Gunduz, Ufuk ^a   Keskin, Tugba ^a   Tansik, Gulistan ^a   Mutlu, Pelin ^a   Yalcin, Serap ^b   Unsoy, Gozde ^a   Yakar, Arzu ^c   Khodadust, Rouhollah ^a   Gunduz, Gungor ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Drug delivery; Folic acid; Idarubicin; Magnetic nanoparticle; MCF 7; Polyethylene glycol (PEG)

Indexed keywords

FOLIC ACID; IDARUBICIN; MACROGOL; MAGNETIC NANOPARTICLE; NANOCARRIER; ANTINEOPLASTIC AGENT; MAGNETITE NANOPARTICLE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED DRUG RELEASE; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT SCATTERING; MCF 7 CELL LINE; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; METABOLISM; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FEMALE; FOLIC ACID; HUMANS; IDARUBICIN; MAGNETITE NANOPARTICLES; MCF-7 CELLS;

EID: 84908061950     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.08.013     Document Type: Article

References (37)

1. Van Vlerken L.E., Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006, 3:205-216.
2. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.
3. Takimoto C.H., Calvo E. Principles of oncologic pharmacotherapy. Cancer Management: A Multidisciplinary Approach 2008, UBM Medica, Norwalk. R. Pazdur, L.D. Wagman, K.A. Camphausen, W.J. Hoskins (Eds.).
4. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56:185-229.
5. Gubernator J., Chwastek G., Koryciń ska M., Stasiuk M., Grynkiewicz G., Lewrick F., et al. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. J Control Release 2010, 146:68-75.
6. Hande K.R. Topoisomerase II inhibitors. Update Cancer Ther 2008, 3:13-26.
7. Ma P., Dong X., Swadley C.L., Gupte A., Leggas M., Ledebur H.C., et al. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol 2009, 5:151-161.
8. Hamman J.H. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar Drugs 2010, 8:1305-1322.
9. Arulmozhi V., Pandian K., Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerf 2013, 110:313-320.
10. Javid A., Ahmadian S., Saboury A.A., Kalantar S.M., Rezaei-Zarchi S. Chitosan coated superparamagnetic iron oxide nanoparticles for doxo rubicin delivery: synthesis and anticancer effect against human ovarian cancer cells. Chem Biol Drug Des 2013, 82:296-306.
11. McBain S.C., Yiu H.H.P., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008, 3:169-180.
12. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
13. Sun C., Lee J.S.H., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
14. Moghimi S.M., Peer D., Langer R. Reshaping the future of nanopharmaceuticals: ad iudicium. ACS Nano 2011, 5:8454-8458.
15. Xiao Z., Levy-Nissenbaum E., Alexis F., Lupták A., Teply B.A., Chan J.M., et al. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 2012, 6:696-704.
16. Perfezou M., Turner A., Merkoçi A. Cancer detection using nanoparticle-based sensors. Chem Soc Rev 2012, 41:2606-2622.
17. Byrne J.D., Betancourt T., Peppas L.B. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60:1615-1626.
18. Lu Y., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002, 54:675-693.
19. Liu X., Kaminski M., Guan Y., Chen H., Liu H., Rosengart A.J. Preparation and characterization of hydrophobic superparamagnetic magnetite gel. J Magn Mater 2006, 306:248-253.
20. Yallapu M.M., Foy S.P., Jain T.K., Labhasetwaar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res 2010, 27:2283-2295.
21. Zhang J., Rana S., Sriavastava R.S., Misra R.D.K. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater 2008, 4:40-48.
22. Kultarne S.A., Low P.S. Targeting of nanoparticles: folate receptor. Methods in Molecular Biology. 2010, 249-265. Humana Press, Springer Science+Business Media, LLC, New York. S.R. Grobmyer, B.M. Moudgil (Eds.).
23. Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polm Sci Polym Symp 1975, 51:135-153.
24. Moghimi S.M., Hunter A.C. Poloxamers and poloxamines in nanoparticles engineering and experimental medicine. Trends Biotechnol 2000, 18:412-420.
25. Park E.K., Lee S.B., Lee Y.M. Preparation and characterization of methoxypoly(ethylene glycol)/poly(epsiloncaprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005, 26:1053-1061.
26. Storm G., Belliot S.O., Daemen T., Lasic D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 1995, 17:31-48.
27. Oyewumi M.O., Yokel R.A., Jay M., Coakley T., Mumper R.J. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 2004, 95:613-626.
28. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
29. Peppas L.B., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
30. Unsoy G., Khodadust R., Yalcin S., Mutlu P., Gunduz U. Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci 2014, 62:243-250.
31. Khodadust R., Mutlu P., Yalcin S., Unsoy G., Gunduz U. Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles. J Pharm. Sci 2013, 102:1825-1835.
32. Yalcin S., Erkan M., Unsoy G., Parsian M., Kleeff J., Gunduz U. Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines. Biomed Pharmacother 2014, 10.1016/j.biopha.2014.07.003.
33. Engin K., Leeper D.B., Cater J.R., Thistlethwaite A.J., Tupchong L., McFarlane J.D. Extracellular pH distribution in human tumors. Int J Hyperth 1995, 11:211-216.
34. 31P probes. NMR Biomed 1999, 12:495-504.
35. Jain R., Dandekar P., Loretz B., Melero A., Stauner T., Wenz Gi Koch M., et al. Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol. Int J Pharm 2011, 420:147-155.
36. Stein W.D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 1997, 77:545-590.
37. Santos N.D., Waterhouse D., Masin D., Tardi P.G., Karlsson G., Edwards K., et al. Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. J Control Release 2005, 105:89-105.